{
    "pmid": "14582591",
    "journal": "Acta odontologica Scandinavica",
    "publication_type": "Clinical Trial",
    "publication_year": "2004",
    "publication_date": "2004-02-04",
    "title": "Plasma levels of lidocaine, o-toluidine, and prilocaine after application of 8.5 g Oraqix in patients with generalized periodontitis: effect on blood methemoglobin and tolerability.",
    "first_author": "Britt-Marie Herdevall",
    "corresponding_author": "Mohamed Abdel-Rehim",
    "authors": "Britt-Marie Herdevall, Bj\u00f6rn Klinge, Lena Persson, Gunilla Huledal, Mohamed Abdel-Rehim",
    "affiliations": "(1) Specialist Dental Clinic, S\u00f6dert\u00e4lje, Sweden. ['Britt-Marie Herdevall']",
    "abstract": "Oraqix, a novel non-injectable anesthetic gel containing lidocaine and prilocaine and a thermosetting agent has been developed to provide localized anesthesia in periodontal pockets during scaling/root planing (SRP). The aim of this open study was to determine the plasma levels of lidocaine and prilocaine following application of 8.5 g Oraqix (5 cartridges) to 11 patients with generalized periodontitis (> or = 49% of tooth pockets > or = 5 mm and > or = 23% of pockets > or = 6 mm). Oraqix was applied to the pockets during periodontal probing and SRP over a 2.6 3.4 h period. Blood samples were collected up to 10 h after the start of application of Oraqix. Peak plasma levels of lidocaine (0.16-0.55 mg/L) and prilocaine (0.05-0.18 mg/L) occurred 2.0-3.7 h and 2.0-3.3 h, respectively, after the start of application of Oraqix. These levels are well below threshold levels for initial signs of central nervous system (CNS) toxicity. In conclusion, application of 8.5 g Oraqix (212.5 mg of lidocaine base and 212.5 mg of prilocaine base) in periodontal pockets was well tolerated and displayed a wide safety margin with respect to plasma levels normally associated with systemic toxicity.",
    "keywords": "",
    "MeshHeadingList": [
        {
            "QualifierName": [],
            "DescriptorName": "Adult"
        },
        {
            "QualifierName": [],
            "DescriptorName": "Aged"
        },
        {
            "QualifierName": [],
            "DescriptorName": "Anesthesia, Dental"
        },
        {
            "QualifierName": [
                "blood",
                "toxicity"
            ],
            "DescriptorName": "Anesthetics, Combined"
        },
        {
            "QualifierName": [
                "blood",
                "toxicity"
            ],
            "DescriptorName": "Anesthetics, Local"
        },
        {
            "QualifierName": [],
            "DescriptorName": "Dental Scaling"
        },
        {
            "QualifierName": [],
            "DescriptorName": "Female"
        },
        {
            "QualifierName": [],
            "DescriptorName": "Humans"
        },
        {
            "QualifierName": [
                "blood",
                "pharmacokinetics",
                "toxicity"
            ],
            "DescriptorName": "Lidocaine"
        },
        {
            "QualifierName": [],
            "DescriptorName": "Lidocaine, Prilocaine Drug Combination"
        },
        {
            "QualifierName": [],
            "DescriptorName": "Male"
        },
        {
            "QualifierName": [
                "analysis"
            ],
            "DescriptorName": "Methemoglobin"
        },
        {
            "QualifierName": [],
            "DescriptorName": "Middle Aged"
        },
        {
            "QualifierName": [
                "therapy"
            ],
            "DescriptorName": "Periodontal Pocket"
        },
        {
            "QualifierName": [
                "blood",
                "pharmacokinetics",
                "toxicity"
            ],
            "DescriptorName": "Prilocaine"
        },
        {
            "QualifierName": [
                "blood",
                "pharmacokinetics"
            ],
            "DescriptorName": "Toluidines"
        }
    ],
    "ChemicalList": [
        {
            "RegistryNumber": "0",
            "NameOfSubstance": "Anesthetics, Combined"
        },
        {
            "RegistryNumber": "0",
            "NameOfSubstance": "Anesthetics, Local"
        },
        {
            "RegistryNumber": "0",
            "NameOfSubstance": "Lidocaine, Prilocaine Drug Combination"
        },
        {
            "RegistryNumber": "0",
            "NameOfSubstance": "Toluidines"
        },
        {
            "RegistryNumber": "046O35D44R",
            "NameOfSubstance": "Prilocaine"
        },
        {
            "RegistryNumber": "9008-37-1",
            "NameOfSubstance": "Methemoglobin"
        },
        {
            "RegistryNumber": "98PI200987",
            "NameOfSubstance": "Lidocaine"
        },
        {
            "RegistryNumber": "B635MZ0ZLU",
            "NameOfSubstance": "2-toluidine"
        }
    ],
    "doi": null,
    "journal_sjr": 0.0,
    "journal_h_index": 0,
    "journal_if": 1.573,
    "journal_metrics": [
        1.573,
        0,
        0.0,
        1.785
    ],
    "bacteria_entities": {},
    "has_bacteria_ner": true,
    "bacteria": [],
    "has_bacteria_norm": true,
    "nutrient_entities": {},
    "has_nutrient_ner": true,
    "chemical_entities": {
        "0": [
            [
                "Oraqix",
                0,
                1
            ],
            [
                "lidocaine",
                10,
                11
            ],
            [
                "prilocaine",
                12,
                13
            ]
        ],
        "1": [
            [
                "lidocaine",
                13,
                14
            ],
            [
                "prilocaine",
                15,
                16
            ]
        ],
        "3": [
            [
                "Oraqix",
                14,
                15
            ]
        ],
        "4": [
            [
                "lidocaine",
                4,
                5
            ],
            [
                "prilocaine",
                14,
                15
            ],
            [
                "Oraqix",
                42,
                43
            ]
        ],
        "6": [
            [
                "Oraqix",
                7,
                8
            ],
            [
                "lidocaine",
                12,
                13
            ],
            [
                "prilocaine",
                18,
                19
            ]
        ]
    },
    "has_chemical_ner": true,
    "has_genetic_ner": true,
    "enzyme_entities": [],
    "metabolic_entities": [
        [
            0,
            [
                [
                    "lidocaine",
                    8,
                    9
                ],
                [
                    "prilocaine",
                    10,
                    11
                ]
            ]
        ],
        [
            1,
            [
                [
                    "lidocaine",
                    13,
                    14
                ],
                [
                    "prilocaine",
                    15,
                    16
                ]
            ]
        ],
        [
            4,
            [
                [
                    "lidocaine",
                    4,
                    5
                ],
                [
                    "prilocaine",
                    10,
                    11
                ]
            ]
        ]
    ],
    "has_metabolic_ner": true,
    "molecule": [
        [
            [
                "Oraqix",
                "MESH:D000077442",
                "Lidocaine, Prilocaine Drug Combination"
            ],
            [
                "lidocaine",
                "MESH:D008012",
                "Lidocaine"
            ],
            [
                "prilocaine",
                "MESH:D011318",
                "Prilocaine"
            ]
        ],
        [
            [
                "lidocaine",
                "",
                ""
            ],
            [
                "Oraqix",
                "",
                ""
            ],
            [
                "prilocaine",
                "",
                ""
            ]
        ]
    ],
    "has_molecular_norm": true,
    "nutrient": [],
    "has_nutrient_norm": true,
    "disease_entities": {
        "1": [
            [
                "periodontitis",
                31,
                32
            ]
        ],
        "6": [
            [
                "toxicity",
                42,
                43
            ]
        ]
    },
    "has_disease_ner": true,
    "disease": [
        [
            "periodontitis",
            "MESH:D010518",
            "Periodontitis"
        ],
        [
            "toxicity",
            "",
            ""
        ]
    ],
    "has_disease_norm": true,
    "affiliation_entities": [
        "Sweden\nS\u00f6dert\u00e4lje",
        "Specialist Dental Clinic"
    ],
    "has_affiliation_ner": true,
    "sample_size_entities": {
        "1": [
            [
                11,
                27,
                28
            ]
        ]
    },
    "sample_size": 11,
    "has_sample_size_ner": true,
    "significance_conclusion": [],
    "has_significance_ner": true,
    "mtime": 1646878748.5657613,
    "htime": "2022-03-10 10:19:08.565761",
    "title_zh": "8.5 g Oraqix\u6cbb\u7597\u5e7f\u6cdb\u6027\u7259\u5468\u708e\u60a3\u8005\u540e\u8840\u6d46\u5229\u591a\u5361\u56e0\u3001\u90bb\u7532\u82ef\u80fa\u548c\u4e19\u6d1b\u5361\u56e0\u6c34\u5e73:\u5bf9\u8840\u9ad8\u94c1\u8840\u7ea2\u86cb\u767d\u548c\u8010\u53d7\u6027\u7684\u5f71\u54cd\u3002",
    "abstract_zh": "Oraqix\u662f\u4e00\u79cd\u65b0\u578b\u7684\u975e\u6ce8\u5c04\u6027\u9ebb\u9189\u5242\u51dd\u80f6\uff0c\u542b\u6709\u5229\u591a\u5361\u56e0\u548c\u4e19\u6d1b\u5361\u56e0\u4ee5\u53ca\u4e00\u79cd\u70ed\u56fa\u6027\u5242\uff0c\u7528\u4e8e\u7259\u5468\u888b\u7684\u5c40\u90e8\u9ebb\u9189\u3002 \u8fd9\u4e2a\u5f00\u653e\u7814\u7a76\u7684\u76ee\u7684\u662f\u786e\u5b9a\u7684\u7b49\u79bb\u5b50\u4f53\u6c34\u5e73\u7684\u5229\u591a\u5361\u56e0\u548c\u4e19\u80fa\u5361\u56e0\u5e94\u75288.5 g Oraqix(5\u58a8\u76d2)11\u5e7f\u4e49\u7259\u5468\u708e\u60a3\u8005(> = 49%\u7684\u7259\u9f7f\u53e3\u888b>\u548c> = 5\u6beb\u7c73\u6216= 23%\u7684\u53e3\u888b>\u6216= 6\u6beb\u7c73)\u3002 \u5728\u7259\u5468\u63a2\u6d4b\u548cSRP\u671f\u95f4\uff0cOraqix\u5e94\u7528\u4e8e\u888b\u4f53\uff0c\u65f6\u95f4\u4e3a2.6 ~ 3.4\u5c0f\u65f6\u3002 \u5728\u5e94\u7528Oraqix 10\u5c0f\u65f6\u540e\u91c7\u96c6\u8840\u6db2\u6837\u672c\u3002 \u5e94\u7528Oraqix\u540e\uff0c\u8840\u6d46\u5229\u591a\u5361\u56e0(0.16-0.55 mg/L)\u548c\u4e19\u6d1b\u5361\u56e0(0.05-0.18 mg/L)\u7684\u5cf0\u503c\u5206\u522b\u51fa\u73b0\u57282.0-3.7 h\u548c2.0-3.3 h\u3002 \u8fd9\u4e9b\u6c34\u5e73\u8fdc\u4f4e\u4e8e\u4e2d\u67a2\u795e\u7ecf\u7cfb\u7edf(CNS)\u4e2d\u6bd2\u7684\u521d\u59cb\u8ff9\u8c61\u7684\u9608\u503c\u6c34\u5e73\u3002 \u603b\u4e4b\uff0c8.5 g Oraqix (212.5 mg\u5229\u591a\u5361\u56e0\u57fa\u548c212.5 mg\u4e19\u6d1b\u5361\u56e0\u57fa\u548c)\u5728\u7259\u5468\u888b\u5185\u7684\u5e94\u7528\u5177\u6709\u826f\u597d\u7684\u8010\u53d7\u529b\uff0c\u76f8\u5bf9\u4e8e\u6b63\u5e38\u60c5\u51b5\u4e0b\u4e0e\u5168\u8eab\u6bd2\u6027\u76f8\u5173\u7684\u8840\u6d46\u6c34\u5e73\uff0c\u663e\u793a\u51fa\u5e7f\u6cdb\u7684\u5b89\u5168\u8fb9\u754c\u3002",
    "has_translated": true,
    "chemical": [
        [
            "Oraqix",
            "MESH:D000077442",
            "Lidocaine, Prilocaine Drug Combination"
        ],
        [
            "lidocaine",
            "MESH:D008012",
            "Lidocaine"
        ],
        [
            "prilocaine",
            "MESH:D011318",
            "Prilocaine"
        ]
    ],
    "gene_entities": {},
    "gene": [],
    "anatomy_entities": {
        "0": [
            [
                ", a",
                1,
                3
            ]
        ],
        "1": [
            [
                "levels of",
                11,
                13
            ],
            [
                "of tooth",
                38,
                40
            ]
        ],
        "2": [],
        "3": [],
        "4": [
            [
                "levels of",
                2,
                4
            ]
        ],
        "5": [
            [
                "central nervous",
                11,
                13
            ],
            [
                "central nervous system",
                11,
                14
            ],
            [
                "nervous system",
                12,
                14
            ],
            [
                "system (",
                13,
                15
            ],
            [
                "central nervous",
                15,
                17
            ],
            [
                "central nervous system",
                15,
                18
            ],
            [
                "nervous system",
                16,
                18
            ]
        ],
        "6": []
    },
    "anatomy": [
        [
            ", a",
            "",
            ""
        ],
        [
            "central nervous",
            "MESH:D002490",
            "Central Nervous System"
        ],
        [
            "central nervous system",
            "MESH:D002490",
            "Central Nervous System"
        ],
        [
            "levels of",
            "",
            ""
        ],
        [
            "nervous system",
            "MESH:D009420",
            "Nervous System"
        ],
        [
            "of tooth",
            "MESH:D014070",
            "Tooth"
        ],
        [
            "system (",
            "",
            ""
        ]
    ],
    "antibody_entities": {},
    "antibody": [],
    "abstract_prep": "Oraqix, a novel non-injectable anesthetic gel containing lidocaine and prilocaine and a thermosetting agent has been developed to provide localized anesthesia in periodontal pockets during scaling/root planing (scaling/root planing). The aim of this open study was to determine the plasma levels of lidocaine and prilocaine following application of 8.5 g Oraqix (5 cartridges) to 11 patients with generalized periodontitis (> or = 49% of tooth pockets > or = 5 mm and > or = 23% of pockets > or = 6 mm). Oraqix was applied to the pockets during periodontal probing and scaling/root planing over a 2.6 3.4 h period. Blood samples were collected up to 10 h after the start of application of Oraqix. Peak plasma levels of lidocaine (0.16-0.55 mg/L) and prilocaine (0.05-0.18 mg/L) occurred 2.0-3.7 h and 2.0-3.3 h, respectively, after the start of application of Oraqix. These levels are well below threshold levels for initial signs of central nervous system (central nervous system) toxicity. In conclusion, application of 8.5 g Oraqix (212.5 mg of lidocaine base and 212.5 mg of prilocaine base) in periodontal pockets was well tolerated and displayed a wide safety margin with respect to plasma levels normally associated with systemic toxicity.",
    "sentence_labels": [
        [
            0,
            "BACKGROUND"
        ],
        [
            1,
            "OBJECTIVE"
        ],
        [
            2,
            "METHODS"
        ],
        [
            3,
            "METHODS"
        ],
        [
            4,
            "RESULTS"
        ],
        [
            5,
            "CONCLUSIONS"
        ],
        [
            6,
            "CONCLUSIONS"
        ]
    ],
    "abstract_highlight": [
        "<bold=True italic=True font_color=#008000>",
        "Oraqix ",
        "<bold=True italic=True font_color=purpule>",
        ", ",
        "<bold=True italic=True font_color=purpule>",
        "a ",
        "novel ",
        "non-injectable ",
        "anesthetic ",
        "gel ",
        "containing ",
        "<bold=True italic=True font_color=#008000>",
        "lidocaine ",
        "and ",
        "<bold=True italic=True font_color=#008000>",
        "prilocaine ",
        "and ",
        "a ",
        "thermosetting ",
        "agent ",
        "has ",
        "been ",
        "developed ",
        "to ",
        "provide ",
        "localized ",
        "anesthesia ",
        "in ",
        "periodontal ",
        "pockets ",
        "during ",
        "scaling/root ",
        "planing ",
        "( ",
        "scaling/root ",
        "planing ",
        ") ",
        ". ",
        "The ",
        "aim ",
        "<bold=True italic=True font_color=purpule>",
        "of ",
        "this ",
        "open ",
        "study ",
        "was ",
        "to ",
        "determine ",
        "the ",
        "plasma ",
        "<bold=True italic=True font_color=purpule>",
        "levels ",
        "of ",
        "<bold=True italic=True font_color=#008000>",
        "lidocaine ",
        "and ",
        "<bold=True italic=True font_color=#008000>",
        "prilocaine ",
        "following ",
        "application ",
        "of ",
        "8.5 ",
        "g ",
        "Oraqix ",
        "( ",
        "5 ",
        "cartridges ",
        ") ",
        "to ",
        "11 ",
        "patients ",
        "with ",
        "generalized ",
        "<bold=True italic=True font_color=#000080>",
        "periodontitis ",
        "( ",
        "> ",
        "or ",
        "= ",
        "49 ",
        "% ",
        "of ",
        "<bold=True italic=True font_color=purpule>",
        "tooth ",
        "pockets ",
        "> ",
        "or ",
        "= ",
        "5 ",
        "mm ",
        "and ",
        "> ",
        "or ",
        "= ",
        "23 ",
        "% ",
        "of ",
        "pockets ",
        "> ",
        "or ",
        "= ",
        "6 ",
        "mm ",
        ") ",
        ". ",
        "Oraqix ",
        "was ",
        "applied ",
        "to ",
        "the ",
        "pockets ",
        "during ",
        "periodontal ",
        "probing ",
        "and ",
        "scaling/root ",
        "planing ",
        "over ",
        "a ",
        "2.6 ",
        "3.4 ",
        "h ",
        "period ",
        ". ",
        "Blood ",
        "samples ",
        "were ",
        "collected ",
        "up ",
        "to ",
        "10 ",
        "h ",
        "after ",
        "the ",
        "start ",
        "of ",
        "application ",
        "of ",
        "<bold=True italic=True font_color=#008000>",
        "Oraqix ",
        ". ",
        "Peak ",
        "plasma ",
        "<bold=True italic=True font_color=purpule>",
        "levels ",
        "<bold=True italic=True font_color=purpule>",
        "of ",
        "<bold=True italic=True font_color=#008000>",
        "lidocaine ",
        "( ",
        "0.16-0.55 ",
        "mg/L ",
        ") ",
        "and ",
        "<bold=True italic=True font_color=#008000>",
        "prilocaine ",
        "( ",
        "0.05-0.18 ",
        "mg/L ",
        ") ",
        "occurred ",
        "2.0-3.7 ",
        "h ",
        "and ",
        "2.0-3.3 ",
        "h ",
        ", ",
        "respectively ",
        ", ",
        "after ",
        "the ",
        "start ",
        "of ",
        "application ",
        "of ",
        "<bold=True italic=True font_color=#008000>",
        "Oraqix ",
        ". ",
        "These ",
        "levels ",
        "are ",
        "well ",
        "below ",
        "threshold ",
        "levels ",
        "for ",
        "initial ",
        "signs ",
        "of ",
        "<bold=True italic=True font_color=purpule>",
        "central ",
        "<bold=True italic=True font_color=purpule>",
        "nervous ",
        "<bold=True italic=True font_color=purpule>",
        "system ",
        "<bold=True italic=True font_color=purpule>",
        "( ",
        "central ",
        "nervous ",
        "system ",
        ") ",
        "toxicity ",
        ". ",
        "In ",
        "conclusion ",
        ", ",
        "application ",
        "of ",
        "8.5 ",
        "g ",
        "<bold=True italic=True font_color=#008000>",
        "Oraqix ",
        "( ",
        "212.5 ",
        "mg ",
        "of ",
        "<bold=True italic=True font_color=#008000>",
        "lidocaine ",
        "base ",
        "and ",
        "212.5 ",
        "mg ",
        "of ",
        "<bold=True italic=True font_color=#008000>",
        "prilocaine ",
        "base ",
        ") ",
        "in ",
        "periodontal ",
        "pockets ",
        "was ",
        "well ",
        "tolerated ",
        "and ",
        "displayed ",
        "a ",
        "wide ",
        "safety ",
        "margin ",
        "with ",
        "respect ",
        "to ",
        "plasma ",
        "levels ",
        "normally ",
        "associated ",
        "with ",
        "systemic ",
        "<bold=True italic=True font_color=#000080>",
        "toxicity ",
        ". "
    ]
}